Technology

ZenaTech (NASDAQ: ZENA) Reports Record 558% Year-Over-Year Revenue Growth to $12.9 Million for Full Year 2025 as Drone as a Service Business Expansion Accelerates...

admin
Total assets grew 188% to $99.8 million; DaaS segment delivered over $10 million in first full year of operations Miami, FL--(Emerging Growth Newswire – April 29, 2026) – EmergingGrowth.com, a leading independent small cap media portal with an extensive history...

مقالات مميزة

Technology

ZenaTech (NASDAQ: ZENA) Reports Record 558% Year-Over-Year Revenue Growth to $12.9 Million for Full Year 2025 as Drone as a Service Business Expansion Accelerates...

Total assets grew 188% to $99.8 million; DaaS segment delivered over $10 million in first full year of operations Miami, FL--(Emerging Growth Newswire – April...
spot_imgspot_img

توك شو

ZenaTech (NASDAQ: ZENA) Reports Record 558% Year-Over-Year Revenue Growth to $12.9 Million for Full Year 2025 as Drone as a Service Business Expansion Accelerates...

Technology
Total assets grew 188% to $99.8 million; DaaS segment delivered over $10 million in first full year of operations Miami, FL--(Emerging Growth...

SBC Medical Group Holdings, Inc. (NASDAQ: SBC) Emerging Growth Research Report – April 22, 2026

Med, Biotech & Pharma
Stay on Target: Long-term accomplished founder and management have shepherded SBC from a solo clinic in 2000 to become a global...
أرني المزيد

فئة نمط

Technology

ZenaTech (NASDAQ: ZENA) Reports Record 558% Year-Over-Year Revenue Growth to $12.9 Million for Full Year 2025 as Drone as a Service Business Expansion Accelerates...

Total assets grew 188% to $99.8 million; DaaS segment delivered over $10 million in first full year of operations Miami, FL--(Emerging Growth Newswire – April...
أرني المزيد
spot_imgspot_img

أخبار عاجلة

أخبار الأدب

ZenaTech (NASDAQ: ZENA) Reports Record 558% Year-Over-Year Revenue Growth to $12.9 Million for Full Year 2025 as Drone as a Service Business Expansion Accelerates...

Technology
Total assets grew 188% to $99.8 million; DaaS segment delivered over $10 million in first full year of operations Miami, FL--(Emerging Growth...

SBC Medical Group Holdings, Inc. (NASDAQ: SBC) Emerging Growth Research Report – April 22, 2026

Med, Biotech & Pharma
Stay on Target: Long-term accomplished founder and management have shepherded SBC from a solo clinic in 2000 to become a global...

Immuron Limited (NASDAQ: IMRN) (ASX: IMC) Emerging Growth Research Report – April 22, 2026

Med, Biotech & Pharma
Immuron reported solid revenue growth for the third quarter of its 2026 fiscal year, ended March 31, 2026. Global sales were...
spot_img

الأكثر شهرة

أحدث المقالات

BuyersStrike Short Attack Ahead of NASDAQ Uplisting

In Play
This morning shares of CytoDyn Inc. (OTMKTS: CYDY) screamed higher in very active trading and touched $7.00 per share to a $4.14...

Mesoblast Crashed on Poor DSMB Report Leaving CytoDyn as Sole Survivor in COVID-19 Therapeutics

In Play
Only Mesoblast (NASDAQ:MESO) and CytoDyn Inc. (OTCMKS: CYDY) had mortality as a primary endpoint in severe to critical COVID-19.

Cracking the FDA Code to COVID-19 Approvals

In Play
100% correlation between this list and an EUA approval 5 drug candidates on the list have not received an EUA 3 drug candidates seem...

Rapid Countermeasure Against COVID-19: Therapeutics Not Vaccines

In Play
In the interim, no patients can get the drug via emergency IND because the FDA has stopped that access. This is a point of moral outrage. By not looking at the interim data for leronlimab in an urgent fashion the FDA is condemning thousands of people to death daily.

Emerging Growth Report; First Graphene (ASX: FGR) Is on the Cusp of Innovation That’s Second to None

ASX Stocks
First Graphene, in a partnership with newGen Group, forwarded graphene solutions to Rio Tinto (ASX: RIO) and BHP Group (ASX: BHP)
1...343536...38Page 35 of 38